ArticlePloS one2025
Data augmentation of time-series data in human movement biomechanics: A scoping review.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neuroscience-Inspired Deep Learning Brain-Machine Interface Decoder.Bioengineering (Basel, Switzerland) · 2026Article
- Human-centered evaluation of statistical parametric mapping and explainable machine learning for outlier detection in plantar pressure data.Scientific reports · 2026Article
- Data Augmentation and Synthetic Data Generation in Rare Disease Research: A Scoping Review.Medical sciences (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe integration of machine learning and deep learning methodologies has transformed data analytics in biomechanics. However, the field faces challenges such as limited large-scale data sets, high data acquisition costs, and restricted participant access that hinder the development of robust algorithms. Additional issues include variability in sensor placement, soft tissue artifacts, and low diversity in movement patterns. These challenges make it difficult to train models that perform reliably across individuals, tasks, and settings. Data augmentation can help address these limitations, but its use in biomechanical time-series data remains insufficiently evaluated.
objectiveThis scoping review on data augmentation for biomechanical time-series data focuses on examining current techniques, evaluating their effectiveness, and offering recommendations for their application.
designFour online databases (PubMed, IEEE Xplore, Scopus, and Web of Science) were used to find studies published between 2013 and 2024. Following PRISMA-ScR guidelines, two screening processes were conducted to identify relevant publications.
results21 publications were identified as relevant. There is no universal best practice for augmenting biomechanical time-series data; instead, methods vary based on study aims. A key issue identified is the absence of soft tissue artifacts in synthetic data, leading to discrepancies and emphasizing the need for realistic techniques. Furthermore, many studies lack proper evaluation of augmentation methods, making it difficult to understand the effects of different techniques. This understanding is crucial for assessing the impact of the augmented data set on downstream models and evaluating the quality of the data augmentation process.
conclusionThis review highlights the importance of data augmentation in addressing limited data availability and improving model generalization in biomechanics. Tailoring augmentation to data characteristics can enhance the performance and relevance of predictive models. However, understanding how different augmentation techniques impact data quality and downstream performance remains essential for developing better methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.